Table 6.
BCLC stage | First treatment at Singhealth Institutions |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Resection, N = 82 | RFA, N = 46 | SIRT, N = 89 | Radiotherapy, N = 4 | TACE, N = 14 | Sorafenib, N = 76 | Other systemic therapy, N = 43 | Clinical trials, N = 78 | Combination therapy, N = 4 | Best supportive care, N = 22 | |
0/A (N = 135) | 71 | 44 | 17 | 1 | 1 | 1 | ||||
B (N = 60) | 7 | 25 | 10 | 8 | 10 | |||||
C (N = 239) | 4 | 1 | 47 | 3 | 3 | 68 | 42 | 67 | 4 (Y90 + systemic) | |
D (N = 24) | 1 | 1 | 22 |
Italicized: number of patients undergoing BCLC compliant treatments. BCLC, Barcelona Clinic Liver Cancer; SIRT, selective internal radiation therapy; NCCS, National Cancer Centre Singapore.